Ken Fisher’s Sarepta Therapeutics SRPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$221K Buy
12,910
+150
+1% +$2.57K ﹤0.01% 947
2025
Q1
$814K Sell
12,760
-5,145
-29% -$328K ﹤0.01% 716
2024
Q4
$2.18M Sell
17,905
-250
-1% -$30.4K ﹤0.01% 572
2024
Q3
$2.27M Buy
18,155
+239
+1% +$29.8K ﹤0.01% 566
2024
Q2
$2.83M Sell
17,916
-105
-0.6% -$16.6K ﹤0.01% 544
2024
Q1
$2.33M Buy
18,021
+4,404
+32% +$570K ﹤0.01% 575
2023
Q4
$1.31M Hold
13,617
﹤0.01% 653
2023
Q3
$1.65M Sell
13,617
-3,603
-21% -$437K ﹤0.01% 663
2023
Q2
$1.97M Buy
17,220
+2,955
+21% +$338K ﹤0.01% 657
2023
Q1
$1.97M Buy
14,265
+1,738
+14% +$240K ﹤0.01% 659
2022
Q4
$1.62M Sell
12,527
-12,317
-50% -$1.6M ﹤0.01% 681
2022
Q3
$2.75M Sell
24,844
-3,962
-14% -$438K ﹤0.01% 523
2022
Q2
$2.16M Sell
28,806
-2,696
-9% -$202K ﹤0.01% 526
2022
Q1
$2.46M Sell
31,502
-78
-0.2% -$6.09K ﹤0.01% 524
2021
Q4
$2.84M Buy
31,580
+138
+0.4% +$12.4K ﹤0.01% 515
2021
Q3
$2.91M Buy
31,442
+3,474
+12% +$321K ﹤0.01% 485
2021
Q2
$2.17M Sell
27,968
-502
-2% -$39K ﹤0.01% 519
2021
Q1
$2.12M Buy
28,470
+267
+0.9% +$19.9K ﹤0.01% 524
2020
Q4
$4.81M Sell
28,203
-4,173
-13% -$711K ﹤0.01% 420
2020
Q3
$4.55M Sell
32,376
-3,907
-11% -$549K ﹤0.01% 403
2020
Q2
$5.82M Sell
36,283
-4,576
-11% -$734K 0.01% 384
2020
Q1
$4M Buy
40,859
+6,633
+19% +$649K 0.01% 377
2019
Q4
$4.42M Sell
34,226
-1,915
-5% -$247K ﹤0.01% 406
2019
Q3
$2.72M Buy
36,141
+693
+2% +$52.2K ﹤0.01% 505
2019
Q2
$5.39M Buy
35,448
+10,788
+44% +$1.64M 0.01% 423
2019
Q1
$2.94M Buy
24,660
+62
+0.3% +$7.39K ﹤0.01% 474
2018
Q4
$2.68M Buy
24,598
+133
+0.5% +$14.5K ﹤0.01% 486
2018
Q3
$3.95M Sell
24,465
-8,722
-26% -$1.41M ﹤0.01% 450
2018
Q2
$4.39M Sell
33,187
-6,044
-15% -$799K 0.01% 447
2018
Q1
$2.91M Sell
39,231
-3,417
-8% -$253K ﹤0.01% 494
2017
Q4
$2.37M Buy
42,648
+6
+0% +$334 ﹤0.01% 505
2017
Q3
$1.93M Buy
+42,642
New +$1.93M ﹤0.01% 501